Call Number (LC) Title Results
RM301.25 .H53 2011 Pharmaco-complexity non-linear phenomena and drug product development / 1
RM301.25 .H54 2024 High performance computing for drug discovery and biomedicine / 1
RM301.25 .H55 2021eb In silico dreams : how artificial intelligence and biotechnology will create the medicines of the future / 1
RM301.25 .H65 1999 NMR spectroscopy in drug development and analysis / 1
RM301.25 .H65 2014eb Theory of drug development / 1
RM301.25 .I43 2010 Imaging in CNS drug discovery and development implications for disease and therapy / 1
RM301.25.I47 2014eb Improving and Accelerating Therapeutic Development for Nervous System Disorders : Workshop Summary. 1
RM301.25 .I48 2006eb In silico technologies in drug target identification and validation 1
RM301.25 .I5 2006eb In vivo MR techniques in drug discovery and development 1
RM301.25 .I5 2013 In silico models for drug discovery /
In silico models for drug discovery
2
RM301.25 .I5 2014eb In vivo models for drug discovery / 1
RM301.25 .I53 2005eb Industrialization of drug discovery : from target selection through lead optimization / 1
RM301.25 .I53 2011 Incentives for Research, Development, and Innovation in Pharmaceuticals / [delta] 1
RM301.25 .I53 2023 Inducing targeted protein degradation : from chemical biology to drug discovery and clinical applications / 1
RM301.25 .I56 1987 Innovation and acceleration in clinical drug development : Merck Sharp & Dohme International Medical Advisory Council, Siena, Italy, June 9-10, 1986 / 1
RM301.25 .I564 2011eb Building a national framework for the establishment of regulatory science for drug development : workshop summary / 1
RM301.25 .I565 2002eb Integrated drug discovery technologies 1
RM301.25 .I57 2002eb Integration of pharmaceutical discovery and development : case histories / 2
RM301.25 .I575 2015 An introduction to high content screening : imaging technology, assay development, and data analysis in biology and drug discovery / 1
RM301.25 .I58 1993 Integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development 1